Pharmabiz

Orchid Pharma to set up Rs. 600 crore India’s first fermentation-based 7-ACA facility in Kathua, Jammu & Kashmir

Orchid Pharma to set up Rs. 600 crore India’s first fermentation-based 7-ACA facility in Kathua, Jammu & Kashmir: Our Bureau, ...
Pharmabiz

ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market

ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market ...
Pharmabiz

First World Health Congress sees India to become a hub for global health collaboration

First World Health Congress sees India to become a hub for global health collaboration: Our Bureau, Chennai Tuesday, March 17 ...
Pharmabiz

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia: Basel, Switzerland ...
Pharmabiz

Pulse of Positivity Health and Wellness Summit 2026 brings policymakers, doctors, to shape the future of health in India

Pulse of Positivity Health and Wellness Summit 2026 brings policymakers, doctors, to shape the future of health in India: Our Bureau, Bengaluru Tuesday, March 17, 2026, 14:40 Hrs ...
Pharmabiz

Merck to present new data from cardio-pulmonary pipeline at the ACC.26 in New Orleans, from March 28-30

Merck to present new data from cardio-pulmonary pipeline at the ACC.26 in New Orleans, from March 28-30: Rahway, New Jersey Tuesday, March 17, 2026, 17:00 Hrs [IST] Merck, known a ...
Pharmabiz

National conference on next-gen pharma trends hosted at GNIP Dalewal

National conference on next-gen pharma trends hosted at GNIP Dalewal: Our Bureau, Chennai Tuesday, March 17, 2026, 17:30 Hrs [IST] The Guru Nanak Institute of Pharmacy (GNIP) at D ...
Pharmabiz

GN Store Nord enters into agreement to sell its hearing business to Amplifon for DKK 17.0 billion

GN Store Nord enters into agreement to sell its hearing business to Amplifon for DKK 17.0 billion: Denmark Tuesday, March 17, 2026, 14:00 Hrs [IST] GN Store Nord A/S (GN) has ente ...
Pharmabiz

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...
Pharmabiz

Lundbeck to present phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease at the 2026 AD/PD conference

Lundbeck to present phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease at the 2026 AD/PD conference: Valby, Denmark Tuesday, ...
Pharmabiz

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...
Pharmabiz

Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index

Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index: Irvine, California Tuesday, March 17, 2026, 16:00 Hrs [IST] Allergan Aesthetics, an Abb ...